Zevra Therapeutics, Inc. (ZVRA)

NASDAQ: ZVRA · Real-Time Price · USD

11.61

-0.23 (-1.94%)

At close: Sep 18, 2026, 4:00 PM EDT

11.77

+0.16 (1.38%)

Pre-market: Sep 21, 2026, 8:02 AM EDT

Zevra Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	136.07	106.47	23.61	27.46	10.16	28.65
Revenue Growth	119.40%	350.92%	-14.02%	170.26%	-64.53%	115.61%
Gross Profit	129.89	89.99	16.2	25.29	9.94	26.59
Operating Income	39.07	-4.23	-87	-49.6	-24.9	7.73
Net Income	57.25	77.59	-105.51	-46.05	-26.77	-62.9
Earnings Per Share	0.96	1.35	-2.28	-1.30	-0.78	-2.11
EPS Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	221.57	191.01	69.5	67.74	82.85	112.35
Total Debt	1.5	63.21	60.3	43.77	14.13	1.61
Net Cash (Debt)	220.07	127.81	9.2	23.97	68.72	110.74
Net Cash Growth	56.82%	1289.18%	-61.62%	-65.11%	-37.95%	-
Net Cash Per Share	3.69	2.23	0.20	0.68	1.99	3.72

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	33.4	-1.6	-69.67	-33.54	-18.72	10.44
Capital Expenditures	-0.78	-0.84	-	-0.3	-0.09	-0.1
Free Cash Flow	32.62	-2.43	-69.67	-33.83	-18.81	10.34
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	95.46%	84.52%	68.59%	92.09%	97.81%	92.81%
Operating Margin	28.71%	-3.98%	-368.47%	-180.63%	-245.07%	26.98%
Pretax Margin	50.92%	81.41%	-381.76%	-167.69%	-263.80%	-29.74%
Profit Margin	42.07%	72.87%	-446.85%	-167.69%	-263.48%	-219.54%
FCF Margin	23.98%	-2.28%	-295.04%	-123.20%	-185.12%	36.08%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.09	6.50	-	-	-	-
Forward PE	13.61	19.15	102.50	102.50	102.50	24.17
P/FCF Ratio	21.13	-	-	-	-	29.76
PS Ratio	5.07	4.74	18.85	9.90	15.59	10.74